eCardio Opens Independent Diagnostic Testing Facility in California
HOUSTON, Feb. 4, 2014 /PRNewswire/ -- eCardio Diagnostics (www.ecardio.com), a leader in remote arrhythmia monitoring services, today announced the opening of its second Independent Diagnostic Testing Facility (IDTF) in San Francisco, California.
"This expansion, along with our continued employee and facility growth in Houston, will provide the resources for us to better serve our increasing patient population throughout the United States. We are excited about our growth opportunities in 2014 and beyond," said eCardio's Chairman and Chief Executive Officer, Larry Lawson.
Expanding to the West Coast is a strategic focus for eCardio as it continues to widen its reach and operations across the country.
"The IDTF in San Francisco will enable us to better serve our practices and patients as well as to provide additional support to our Houston monitoring lab," said eCardio's President and Chief Operating Officer, John Untereker.
The new IDTF will further enhance eCardio's strong presence in California and create a closer relationship with the burgeoning West Coast market. This impressive expansion is a testament to eCardio's success and further emphasizes its commitment to providing excellent service to practices and patients nationwide.
eCardio has provided remote cardiac monitoring services since 2004, a decade of excellence and counting. For more information about eCardio, please visit www.ecardio.com.
Headquartered in Houston, Texas, eCardio Diagnostics, LLC is a leading partner in the delivery of optimal patient care by offering the complete wireless monitoring solution for physicians needing accurate and timely arrhythmia detection in the outpatient setting. Winner of numerous awards from the technology, health, and business sectors, eCardio provides a vast array of products including mobile cardiac telemetry (MCT), as well as looping and non-looping event monitors. The recently-introduced eCardio Verite monitor is a revolutionary single component, dual-mode device that utilizes advanced algorithms to auto-detect arrhythmias and transmit recordings in near, real time to innovative web platforms. Our leading-edge diagnostic innovations and digital solutions, combined with our award-winning Monitoring Center provide physicians and their patients with flexible, fast, and accurate arrhythmia monitoring solutions.
SOURCE eCardio Diagnostics